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Leisure-time activity is an important determinant of long-term
weight maintenance after weight loss in the Sibutramine Trial on
Obesity Reduction and Maintenance (STORM trial)1–3
Marleen A van Baak, Edgar van Mil, Arne V Astrup, Nick Finer, Luc F Van Gaal, Jannik Hilsted, Peter G Kopelman,
Stephan Rössner, W Philip James, and Wim HM Saris for the STORM Study Group
ABSTRACT
Background: The success rate of long-term maintenance of weight
loss in obese patients is usually low. To improve the success rate,
determinants of long-term weight maintenance must be identified.
Objective: The objective of the study was to identify determinants
of long-term success in weight maintenance in obese subjects who
completed the Sibutramine Trial on Obesity Reduction and Main-
tenance (n = 261), a multicenter European study of weight loss and
weight maintenance in obesity that combines sibutramine treatment
with dietary restriction and advice on exercise and behavior.
Design: We studied weight maintenance over 18 mo in subjects
who had completed a 6-mo weight-loss phase. Factors included
in the analysis were initial body weight, the percentage of initial
body weight lost, dietary intake, various components of physical
activity (measured with the Baecke questionnaire), the type of
treatment (sibutramine or placebo), age, and sex.
Results: Multiple regression analysis identified treatment group
(sibutramine or placebo), the percentage of the initial body weight
that was lost during the 6-mo weight-loss phase, and the leisure-time
physical activity index as significant determinants of weight mainte-
nance. Together, these 3 factors explained 20% of the variation in
weight maintenance (P < 0.001). Dietary factors, age, and sex were
not significant predictors of weight-maintenance success in this study.
Conclusions: Weight-maintenance success after weight loss is
positively influenced by sibutramine treatment during weight
maintenance, by a greater initial weight loss, and by a higher
leisure-time physical activity index, which reflects higher levels of
activities such as walking and cycling and lower levels of televi-
sion viewing. Am J Clin Nutr 2003;78:209–14.
INTRODUCTION
In most obese patients who are motivated to lose weight, signi-
ficant weight loss can be achieved by using the current strategies
for obesity treatment (1). However, long-term maintenance of this
weight loss is difficult and often unsuccessful. Wing and Hill (2)
recently reviewed studies of weight-loss maintenance. The suc-
cess rate that can be derived from these studies depends on the
definition of success in weight-loss maintenance and the duration
of the follow-up period. A sustained loss of 5–15% of initial body
weight is associated with significant health benefits, especially in
persons with obesity-related comorbidities (3–5). If successful
weight-loss maintenance is defined as an intentional weight loss
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of ≥ 10% of the initial body weight and maintenance of the new
weight for ≥ 1 y, Wing and Hill estimated that at least 21% of over-
weight or obese persons may be regarded as successful. Ayyad and
Andersen (6) reviewed more long-term (3–14 y; median: 5 y) suc-
cess in weight maintenance and defined weight-maintenance suc-
cess by 2 criteria: maintenance of the entire initial weight loss or
maintenance of ≥ 9–11 kg of the initial weight loss. Overall, a
median of 15% (range: 0–49%) of the patients met one of these
criteria for success. Obviously, there is a clear need to improve
the long-term success rate of weight-loss therapies. To further
improve the success rate of long-term weight management after
weight loss, it is necessary to elucidate the determinants of suc-
cessful weight maintenance.
The Sibutramine Trial on Obesity Reduction and Maintenance
(STORM trial) is a multicenter European study of weight loss and
long-term weight maintenance in obese persons that combines
sibutramine treatment with dietary restriction, exercise advice, and
behavioral advice. The main results of the STORM trial were
reported previously (7). The main outcome was that, of the sub-
jects who completed the trial, 43% of those in the sibutramine-
treated group maintained ≥ 80% of their original weight loss,
whereas only 16% of those in the placebo-treated group did so
over an 18-mo follow-up weight-maintenance period. However,
there were large interindividual variations in weight maintenance
within the sibutramine-treated and placebo-treated groups. The
design of the STORM trial allows the study of a number of factors
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TABLE 1
Characteristics of subjects in the total sample and in the 2 treatment groups1
Sibutramine group Placebo group Total sample
(n = 204) (n = 57) (n = 261)
Sex
Female [n (%)] 168 (82.3) 46 (80.7) 214 (82.0)
Male [n (%)] 36 (17.7) 11 (19.3) 47 (18.0)
Age (y) 41.4 ± 9.72 41.3 ± 10.0 41.4 ± 9.8
BMI (kg/m2)
Month 0 36.6 ± 4.2 37.1 ± 3.8 36.8 ± 4.2
Month 6 32.0 ± 4.0 32.7 ± 3.7 32.2 ± 3.9
1 There were no significant differences between the 2 groups.
2 x– ± SD.
related to treatment, dietary intake, and physical activity and of
their association with long-term weight maintenance. In a recent
analysis, Hansen et al (8) showed that 8–9% of the variation in
weight loss from baseline to follow-up in the STORM trial could
be explained by baseline body weight, treatment group (ie, sibu-
tramine or placebo), and age. In the current analysis, we focused
on weight maintenance during the 18 mo after the initial 6-mo
weight-loss phase and included in the analysis additional factors,
such as initial body weight (month 0); changes in body weight,
dietary intake, and physical activity during the weight-loss phase
(0–6 mo); type of treatment (sibutramine or placebo); and dietary
intake and physical activity level (total activity and that associ-
ated with work, sports, or other leisure-time activities) during the
weight-maintenance phase (6–24 mo).
SUBJECTS AND METHODS
The STORM trial comprises a 6-mo, open-label, run-in,
weight-loss phase that is followed by an 18-mo, double-blind, ran-
domized, placebo-controlled, weight-maintenance phase.
Subjects
Initially, 605 obese subjects aged 17–65 y with a body mass
index (in kg/m2) of 30–45 were recruited for the study. After the
6-mo run-in phase, 467 subjects were randomly assigned in a
ratio of 3 to 1 to receive sibutramine (10–20 mg/d, depending on
maintenance of weight loss) or placebo during an 18-mo
weight-maintenance phase. Of the initial 605 subjects, 261
completed the study—204 who received sibutramine and 57
who received placebo during the weight-maintenance phase.
Ethical approval for the study was obtained from each of the
participating institutions.
Design
During the 6-mo run-in phase, all subjects were treated with
sibutramine (10 mg/d) in combination with a prescribed 600-kcal
deficit diet with < 30% of energy from fat and 15% of energy from
protein. Advice to increase physical activity was given (9, 10). In
addition, information on behavioral modification was provided. A
dietitian saw the subjects every 2 wk. Subjects who lost > 5% of
their initial weight during the 6-mo run-in phase were randomly
assigned for the weight-maintenance phase.
During the 18-mo weight-maintenance phase, subjects were
given dietary advice to maintain weight and were seen every 4
wk by a dietitian, who encouraged them to remain physically
active. Body weight, dietary intake, and physical activity were
determined at baseline. These measurements were repeated at 6,
12, 18 (except physical activity), and 24 mo. In addition, both
the dietitian and the subject estimated dietary compliance on a
5-point scale (1 = full, 5 = none) at the end of the follow-up
period (24 mo).
Methods
Dietary intake was assessed from 4-d (including one weekend
day) food diaries completed by the subjects. National food tables
and programs were used to calculate energy and nutrient intakes.
Physical activity levels were obtained from the Baecke question-
naire (11), which was completed by the subjects. This validated
and reproducible questionnaire quantifies various components of
physical activity (work, sports, other leisure-time activities, and
total activity). Each component is expressed as an index. The work
index is derived from the subject’s main occupation; the frequency
of sitting, standing, walking, lifting heavy loads, and sweating
during work; tiredness after work; and the subject’s estimation of
the physical demands of his or her job in comparison with those
of the subject’s age peers. The sports index is derived from the 2
most frequently played sports with an estimation of their intensity
and the number of hours per week and of months per year these 2
sports are played by the subject, an estimation of the level of phys-
ical activity compared with that of the subject’s age peers, the fre-
quency of sweating during leisure time, and the frequency of play-
ing sports. The leisure-time physical activity index is based on the
frequency of television viewing, walking, and cycling and on the
time spent walking or cycling for transportation.
Data analysis
Results were analyzed only in those subjects who completed
the study (n = 261) and are reported as means (± SDs). Weight
maintenance was calculated as the percentage of the body-weight
loss during the weight-loss phase (months 0–6) that was main-
tained during the weight-maintenance phase (months 6–24).
Changes in body weight, macronutrient intake, and physical activ-
ity during the weight-loss phase were calculated (0–6 mo). Dur-
ing the weight-maintenance phase, dietary intakes and physical
activity scores were averaged over the period of 12–24 mo. The
values at 6 mo were not included in the mean for the weight-main-
tenance phase because they were collected at the end of the
weight-loss phase. However, including the values at 6 mo did not
change the results significantly.
Changes in the variables during the weight-maintenance period
were analyzed by repeated-measures analysis of variance and post hoc
paired t test with Bonferroni correction for multiple comparisons.
Simple regression analysis with percentage of weight (loss) main-
tained as the independent variable was performed. Multivariate step-
wise regression analysis was applied to ascertain which factors con-
tributed independently to weight maintenance. Factors were included
in the regression model if their contribution was significant at P < 0.05.
RESULTS
The 261 subjects (214 women, 47 men) included in this analy-
sis had a mean age of 41.4 ± 9.8 y and a mean body mass index of
36.8 ± 4.2 at the start of the study. After randomization, there was
no difference in sex distribution, age, or body mass index between
the treatment groups (Table 1).
Body-weight loss after the 6-mo run-in phase was 12.4 ± 4.6%
(range: 5.0–29.5%), and it did not differ significantly between
the groups that subsequently were randomly assigned to placebo
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FIGURE 1. Mean (± SD) body weight in sibutramine-treated (; n = 204)
and placebo-treated (; n = 57) groups in the weight-loss phase (month
0–month 6) and in the weight-maintenance phase (month 6–month 24).
Repeated-measures ANOVA: main effect of time, P < 0.001; main effect
of treatment, P = 0.022; time  treatment interaction, P < 0.001. *Signi-
ficant difference between groups, P < 0.01 (post hoc ANOVA, adjusted
according to Bonferroni).
or sibutramine treatment (11.9 ± 3.9% and 12.6 ± 4.8%, respec-
tively; P = 0.31) (Figure 1). During the follow-up phase, there
was a significant increase in body weight (repeated-measures
analysis of variance, P < 0.0001), which differed between the
placebo- and sibutramine-treated subjects (time  treatment
interaction, P < 0.0001). Body weight remained significantly
lower in the sibutramine-treated group than in the placebo-treated
group. Body weight in both groups at the end of follow-up
(month 24) was significantly (P < 0.001) lower than that at base-
line (month 0) (post hoc analysis of variance with Bonferroni cor-
rection) (Figure 1).
The mean values of the studied variables at the various time
points are shown in Table 2. Body weight, energy intake, and rel-
ative fat intake decreased during the 6-mo weight-loss phase. Dur-
ing follow-up, these variables gradually increased, but, at month
24, they were still significantly lower than at baseline. The total
and sports activity indexes and the relative protein and carbohy-
drate intakes increased during the weight-loss phase, gradually
decreased during the follow-up, but were still significantly higher
at month 24 than at baseline. The leisure-time physical activity
index also increased during the weight-loss phase, and this
increase was maintained during follow-up. The work activity
index did not change during the 24-mo study period (Table 2). At
baseline, the sports and leisure-time physical activity indexes were
correlated (r = 0.254, P < 0.001), but neither the leisure-time and
work activity indexes nor the sports and work activity indexes
were significantly correlated.
The simple correlation coefficients of various variables with
weight maintenance are shown in Table 3. Statistically significant
correlations were found for the initial body-weight loss [body
weight (0–6 mo)]; for the total, sports, and leisure-time physical
activity indexes during follow-up; and for fat intake as a percent-
age of energy during follow-up. Multivariate stepwise regression
analysis with these variables and treatment group as the inde-
pendent variables and weight maintenance as the dependent vari-
able identified the following independent predictors of weight
maintenance: treatment group (sibutramine or placebo), the per-
centage of the initial body weight lost, and leisure-time physical
activity index. The regression equation was as follows:
Percentage of weight loss maintained = 71.293 
 39.10  treatment group (1, sibutramine; 
2, placebo) + 3.162  body weight (0–6 mo) 
(%) + 16.578  leisure-time physical activity 
index (12–24 mo) (1)
The partial correlation coefficients were 0.302, 0.294, and 0.219,
respectively. Together these 3 determinants explained 20% of the
variation in weight maintenance between subjects (P < 0.001).
The respective contributions were 9% for treatment, 8% for ini-
tial body-weight loss, and 3% for leisure-time physical activity
index. However, these numbers do not necessarily indicate that
leisure-time physical activity is less influential than the other 2
factors. When sex was included as an independent variable in
TABLE 2
Variables studied in the total sample at various time points during the study1
Time points during study P2
Variable Month 0 Month 6 Month 12 Month 18 Month 24 (month 0–month 24)
Total activity index 7.58 ± 1.25 8.37 ± 1.353 8.31 ± 1.313 8.23 ± 1.303,4 <0.0001
Work activity index 2.72 ± 0.69 2.73 ± 0.69 2.72 ± 0.67 2.72 ± 0.65 0.984
Sports activity index 2.12 ± 0.59 2.53 ± 0.683 2.48 ± 0.653 2.44 ± 0.693,4 <0.0001
Leisure-time activity index 2.73 ± 0.72 3.10 ± 0.663 3.11 ± 0.663 3.07 ± 0.653 <0.0001
Energy intake (kcal/24 h) 2183 ± 651 1556 ± 3923 1620 ± 4603,4 1640 ± 4393,5 1662 ± 4523,5 <0.0001
Carbohydrate intake (% of energy) 45.3 ± 7.1 50.7 ± 6.53 50.7 ± 6.93 49.1 ± 6.73,5 50.0 ± 7.53 <0.0001
Fat intake (% of energy) 35.2 ± 6.3 27.0 ± 6.53 27.3 ± 6.83 29.1 ± 7.03,6 29.1 ± 6.73,6 <0.0001
Protein intake (% of energy) 16.0 ± 3.6 19.7 ± 3.33 19.2 ± 3.43 18.6 ± 3.33,6 18.0 ± 3.23,6 <0.0001
1 x– ± SD; n = 261. No significant interactions between time and treatment group were found for these variables.
2 Repeated-measures ANOVA.
3 Significantly different from month 0, P < 0.001 (Bonferroni correction for multiple comparisons).
4–6 Significantly different from month 6 (Bonferroni correction for multiple comparisons): 4 P < 0.05, 5 P < 0.01, 6 P < 0.001.
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the stepwise regression analysis, it did not enter the final predic-
tion equation.
Differences in weight maintenance between placebo- and sibu-
tramine-treated subjects with below- or above-average initial
weight loss and leisure-time physical activity index during follow-
up are shown in Figure 2. Weight maintenance was almost 100%
in the sibutramine-treated subjects with above-average initial
body-weight loss (≥ 12.5%) and leisure-time physical activity
index (≥ 3.1) during follow-up. Almost all body weight lost was
regained in the placebo-treated subjects with below-average initial
body-weight loss and below-average leisure-time physical activ-
ity index during follow-up.
DISCUSSION
The multicenter European STORM trial is a large randomized
trial of weight maintenance after weight loss (7). Weight loss was
induced by a combination of energy restriction, exercise and
behavioral advice, and treatment with sibutramine. During the 18-mo
weight-maintenance phase, subjects were randomly assigned to
placebo or sibutramine treatment, and they continued to receive
dietary and exercise advice. Because of its size, the STORM trial
offers an excellent opportunity for study of the factors that deter-
mine success in weight maintenance.
Many factors may be involved in successful weight mainte-
nance, as recently reviewed by Wing and Hill (2). They suggest
that differences in behavior are stronger predictors of weight
regain than are differences in physiology or metabolism. Three
behaviors were identified in successful weight maintainers: high
levels of physical activity, low dietary fat and high dietary carbo-
hydrate intakes, and regular self-monitoring of weight. Others
have identified factors related to eating behavior as important pre-
dictors of weight maintenance (12–14). For the present study, we
mainly focused on factors related to dietary intake and (compo-
nents of) physical activity. In addition, the roles of sibutramine
treatment, body weight and body-weight changes, age, and sex
were studied. The results of the study indicate that success in
weight maintenance was related to sibutramine treatment, the
initial body-weight loss, and the level of leisure-time physical
activity. Twenty percent of the variation in weight maintenance in
the subject population could be explained by these 3 factors.
The better weight maintenance in the sibutramine-treated group
than in the placebo-treated group was reported previously from
the STORM trial (7) and other long-term trials on the effective-
ness of sibutramine in weight maintenance (15, 16). Long-term
treatment with another antiobesity drug (orlistat) after weight loss
also was shown to improve weight maintenance (17, 18).
The percentage of the initial body weight that was lost was an
important predictor of successful weight maintenance in this trial.
Anderson et al (19) and Fogelholm et al (20) also identified a
greater weight loss during a very-low-calorie-diet period as a pre-
dictor of better weight maintenance during follow-up (3 y and 10 mo,
respectively). A positive correlation between weight maintenance
and initial weight loss is likely to reflect better compliance with
the treatment, in both the weight-loss and weight-maintenance
phases, in the more successful weight maintainers. This is sup-
ported by the significant (P < 0.0001) negative correlations
between ratings of dietary compliance by the subject and the die-
titian and the weight maintenance at the end of the follow-up
period (month 24) (r = 0.347 and 0.475, respectively).
Many studies identified physical activity as an important deter-
minant of weight maintenance after weight loss (2, 21, 22),
although a review by Fogelholm and Kukkonen-Harjula (13)
showed that one-half of the reviewed randomized interventions
with a prospective follow-up of ≥ 1 y were unable to show better
weight maintenance in subjects assigned to an exercise interven-
tion than in the control group. They suggested that a relatively large
increase in the energy expenditure of physical activity is needed to
improve weight maintenance, but that most interventions either do
not prescribe this amount of expenditure (6.3–8.4 MJ/wk) or are
affected by low adherence to the prescribed exercise program (13).
TABLE 3
Results of simple regression analysis for the total sample with weight
maintenance (% of initial weight loss) as the independent variable1
r P
Age (y) 0.020 0.753
Body weight, 0 mo (kg) 0.038 0.546
Body weight, 0–6 mo (%) 0.289 <0.0001
Total physical activity index, 0–6 mo 0.055 0.381
Work activity index, 0–6 mo 0.036 0.569
Sports activity index, 0–6 mo 0.090 0.148
Leisure-time physical activity index, 0–6 mo 0.033 0.596
Fat intake, 0–6 mo (% of energy) 0.005 0.944
Total physical activity index, 12–24 mo 0.167 0.007
Work activity index, 12–24 mo 0.027 0.668
Sports activity index, 12–24 mo 0.150 0.016
Leisure-time physical activity index, 12–24 mo 0.195 0.002
Fat intake, 12–24 mo (% of energy) 0.125 0.049
Carbohydrate intake, 12–24 mo (% of energy) 0.051 0.421
Protein intake, 12–24 mo (% of energy) 0.089 0.162
1 n = 261. , change.
FIGURE 2. Mean (± SD) weight maintenance (%) in sibutramine- and
placebo-treated groups with a below-average (L) or above-average (H)
leisure-time activity (LLA and HLA, respectively) index during follow-up
(month 12–month 24) and L or H weight loss (LWL and HWL, respectively)
during the initial weight-loss phase (month 0–month 6). Main effects: treat-
ment, P < 0.001; initial body-weight loss, P = 0.0002; leisure-time physical
activity index, P = 0.011. None of the interaction terms were significant:
3-way interaction of leisure-time physical activity index, initial body-weight
loss, and treatment, P = 0.59; two-way interaction for treatment and leisure-
time physical activity index, P = 0.55; interaction for treatment and initial
body-weight loss, P = 0.20; and interaction for leisure-time physical activ-
ity index and initial body-weight loss, P = 0.88.
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The results of our study also identify physical activity as a factor
contributing to successful weight maintenance. The leisure-time
physical activity index, rather than the sports activity or total
activity indexes, predicted weight maintenance success. Physical
activity was determined with the use of the Baecke questionnaire
(11). The validity and reliability of this questionnaire were stud-
ied in various populations (although not specifically in the obese)
by using various methods (23–26).
The scores for total activity and its various components found
in this cohort compare well with those found in other European
populations (11, 25), except for the lower sports activity index in
our study (2.1 compared with 2.4–2.8), which is probably due to
the greater obesity of our population. At baseline, all subjects in
this study were given exercise advice that was based on an aero-
bic exercise program, with walking, cycling, and jogging as the
exercise modalities (9, 10). Reported physical activity increased
during the course of the study, which was reflected in increases in
both the sports and leisure-time physical activity indexes. The
total activity index increased correspondingly. However, the level
of leisure-time activity was the best single physical activity pre-
dictor of success in weight maintenance. Including the sum of the
leisure-time physical and sports activity indexes in the regression
analysis did not increase the amount of explained variance in
weight maintenance. The leisure-time physical activity index is
based on time spent walking, cycling, and watching television. It
is possible that the leisure-time physical activity index is a better
discriminator for a sedentary or more active lifestyle than is the
sports activity index. This would be in line with data from West-
erterp (27) suggesting that daily energy expenditure can be more
readily increased by exchanging sedentary activity for moderate
activity than for vigorous activity.
Data on dietary intake were collected by means of 4-d food
diaries. Baseline intakes of fat, carbohydrate, and protein (35%,
45%, and 16% of energy, respectively) were similar to those in
another large multicenter European trial, the Carbohydrate Ratio
Management in European National diets (CARMEN) study (36%,
44%, and 15% of energy, respectively) (28). During the course of
the study, reported dietary intake changed as expected with the
dietary advice given during the study: energy intake decreased by
500–600 kcal from baseline, fat intake decreased by 6–8% of
energy and was on average < 30% of energy, and the reduction in
relative fat intake was compensated for by an increase in relative
carbohydrate intake. Macronutrient composition of the diet dur-
ing the weight-maintenance phase did not significantly contribute
to success in weight maintenance. This result for fat intake con-
trasts with the results of other studies (14, 29). It is unlikely that
this result was due to a limited variation in dietary fat intake in
response to the dietary advice given during the study, because
reported fat intake during the weight-maintenance phase still
ranged from 14% to 44% of energy. The validity of self-reported
dietary intakes is generally low, even if the reports are collected by
experienced dietitians, as in the STORM trial. In obese subjects,
discrepancies of 20–50% between reported energy intakes and
measured energy expenditures have been described (30). Dis-
crepancies may be due to underreporting, undereating, or both (31,
32). In addition, underreporting has been shown to be selectively
preferential for fat intake (31). It is therefore likely that the
reported energy and macronutrient intake values in our study
underestimate actual intakes. More important, the amounts of
underreporting and undereating show large interindividual varia-
tions (32). Although the changes in dietary intakes measured during
the course of the study (decreased energy and fat intakes and
increased carbohydrate intake) probably reflect real changes, it is
doubtful whether the methods used in this study to determine
dietary intake were sufficiently robust to rank individuals by pro-
portions of fat intake.
In conclusion, we showed that successful weight maintenance
after weight loss (achieved by lifestyle modification and sibu-
tramine treatment) is positively influenced by continued sibu-
tramine treatment during weight maintenance, a greater initial
weight loss, and a higher leisure-time physical activity index. The
leisure-time physical activity index, derived from the Baecke
questionnaire, includes activities such as walking and cycling but
does not include sports activities. Time spent watching television
has a negative effect on the leisure-time physical activity index.
These results suggest that promoting a less sedentary lifestyle with
an increase in time spent on activities such as walking and cycling
may be more effective for weight management than is promoting
an increase in sports activities. Sibutramine treatment, initial
weight loss, and the level of leisure-time physical activity explain
< 20% of the variation in weight maintenance between persons,
which indicates that other factors such as those related to eating
behavior and metabolic susceptibility to weight gain, which were
not addressed in this study, also play an important role.
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